RNK Health review

RNK’s homepage-linked plans make monthly versus longer billing periods easy to compare, and its renewal policy gives a clear 72-hour cancellation cutoff. Other active offers show different prices, while legal terms reserve possible pharmacy charges despite all-in marketing. Get the offer, included fees and refund terms confirmed for the plan you select.

A telehealth service run by RNK Health LLC, a company whose terms are governed by New York law. It sells compounded NAD⁺ in three routes (injection, nasal spray and liposomal liquid, chosen on one page at one price), sermorelin by injection, enclomiphene, compounded semaglutide and tirzepatide, a B12-MIC injection, naltrexone with vitamin B6 for cutting back on alcohol, and an 80-plus-biomarker DNA panel. Its homepage promises "Semaglutide, TRT, & Peptides", but there is no testosterone on the menu; the closest product is enclomiphene, a selective estrogen receptor modulator that prompts your own testosterone production rather than supplying hormone. That is why it is not covered here as a TRT provider.

A public quiz leads to clinician review and, if appropriate, a prescription. Terms allow questionnaire-based or live care depending on the patient and state, and name OpenLoop Healthcare Partners, Reliant MD Medical Associates and MD Integrations among the medical relationships. Independent pharmacies dispense; a footer supplies a Springville, Utah address and phone number without naming the pharmacy business. Its all-50-state service claim is subject to medication and program restrictions, rather than guaranteed access to every product. Required labs are described in subscription inclusions subject to the product and provider. Cancel, pause or skip through the account or support; cancellation must reach RNK at least 72 hours before the next bill. Its policy promises a reminder seven days before renewal.

The homepage-linked NAD⁺ and sermorelin pages show $169/month billed monthly, $149/month billed every three months, or $129/month billed every six months; shipment is monthly. The longer rates imply calculated totals of $447 and $774, but the public tables do not independently print a selected first debit. NAD⁺ injection, nasal spray and liposomal liquid selectors display the same tier prices.

Other active landing pages differ: /nad advertises a $69/month starting offer and /sermorelin $179/month without reconciling those figures with the homepage-linked plans. A $129 all-in block also requires care because the plan picker reaches that equivalent only at six months. Product and refund copy include clinical support, medication and shipping, while the terms reserve potential separate pharmacy product, dispensing and shipping fees. Confirm what your selected price covers.

The detailed refund policy says rebills are final and generally nonrefundable after intake submission, with limited medical-disqualification and fulfillment remedies. Damaged, incorrect or missing medication is normally replaced, with refunds considered if replacement cannot be arranged. The separate NAD⁺ 30-day guarantee conflicts with those restrictions; do not rely on it without written confirmation.

Compounded, which is our statement rather than theirs, because the site never makes it. The homepage, the product pages, the terms and the refund policy contain no mention of the FDA at all. RNK describes its medications only as "USA Compounded: Lab-tested, high-purity medications", and the terms say the pharmacies compound "where applicable". Nowhere does it tell you that compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, quality or effectiveness, and no page carries a citation. Against that silence sit strong claims: NAD⁺ brings "Laser Focus: Clear the brain fog instantly" and lets you "Age Backwards: Repair your cells from the inside out", and semaglutide offers "Effortless Weight Loss". The enclomiphene page goes furthest, promising "the muscle, energy, and drive of TRT without the side effects on your fertility" and labeling the product "Fertility Safe", an unqualified safety claim for a drug that is not FDA-approved for any use. Naltrexone is different: it is an FDA-approved drug for alcohol dependence with decades of trials behind it, and the page's comparison with rehab is fair in outline. On the evidence for the rest: injected, intranasal and liposomal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN raise blood NAD⁺, which is a marker, not a proven benefit. Sermorelin acts on a real growth-hormone axis with thin long-term outcome data. Individual results vary.